|
Quotes & Info
|
| PBTH > SEC Filings for PBTH > Form 8-K on 24-Feb-2012 | All Recent SEC Filings |
24-Feb-2012
Regulation FD Disclosure, Financial Statements and Exhibits
On February 24, 2012, PROLOR Biotech, Inc., a Nevada corporation (the "Company"), is presenting certain poster-slides (the "Presentation") at the European Association for Haemophilia and Allied Disorders (EAHAD) 5th Annual Congress in Rome, Italy. A copy of the Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 7.01.
The information contained in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing by the Company under the Securities Act of 1933, as amended.
(d) Exhibits.
Exhibit
Number Description
99.1 Poster Slides
|
|
|